Moreover, HDAC inhibitors could regulate CRTH2 expression and PGD2 production, and CRTH2 inhibitor AZD1981 and high-concentration PGD2 enhanced their anti-tumor effects in DLBCL. The gene discussed is HDAC9; the disease is diffuse large B-cell lymphoma.